4,4',4'',4'''-(ethene-1,1,2,2-tetrayl)tetraphenol, 98%, 25g

1-(5-Bromopyridin-3-yl)piperazine, 95.0%, 25g

4-Nitro-2-(trifluoromethyl)benzene-1-sulfonyl chloride, 98%, 100mg

tert-Butyl 4-[[(Methylsulfonyl)oxy]methyl]piperidine-1-carboxylate>95.0%(HPLC)(T)1g

1-(3-Chlorophenyl)-3-thiophen-2-yl-1H-pyrazole-5-carboxylic acid, = 98% (HPLC), 250mg

(S)-1-(4-(Trifluoromethoxy)phenyl)propan-1-amine hydrochloride, 95.0%, 1g

Sodium acetate, anhydrous, 99.0%, 100g

tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate, 95.0%, 250mg

TERT-BUTYL 4-(BROMOMETHYL)-3,5-DIFLUOROBENZOATE, 97.0%, 250mg

1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one, 95.0%, 250mg

5-Bromo-4-chloroindoxyl Acetate>98.0%(HPLC)50mg

5-(3-Hydroxyphenyl)-1,3,4-thiadiazole-2-amine, 95%, 1g

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g